• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Clavesin-2 (CLVS2)

ACP04068

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP04068 Target NameCLVS2
Target SynonymsbA160A10.4; C6orf212; C6orf213; Clavesin-2; clvs2; CLVS2_HUMAN; Retinaldehyde-binding protein 1-like 2; RLBP1L2FormLiquid or Lyophilized powder
Expression SystemE.coliExpression Range1-327aa
Mol Weight54.0kDaProtein LengthFull length
PurityGreater than 90% as determined by SDS-PAGE.Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ5SYC1
Background Information
  • Uniprot Id

    Q5SYC1

  • Target Species

    Human

  • Target Name

    CLVS2

  • Target Full Name

    Clavesin-2

  • Target Function

    Required for normal morphology of late endosomes and/or lysosomes in neurons. Binds phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2).

  • Target Subcellular Location

    Golgi apparatus, trans-Golgi network membrane; Peripheral membrane protein. Cytoplasmic vesicle, clathrin-coated vesicle. Early endosome membrane; Peripheral membrane protein.

  • Target Research Area

    Signal Transduction

  • Target Synonyms

    bA160A10.4; C6orf212; C6orf213; Clavesin-2; clvs2; CLVS2_HUMAN; Retinaldehyde-binding protein 1-like 2; RLBP1L2

  • Target Background

    This gene encodes a protein that belongs to the SEC14/CRAL-TRIO family of proteins. A similar protein in rat is thought to function in the endosomal pathway between early endosomes and mature lysosomes.

Inquire Recombinant Human Clavesin-2 (CLVS2) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification